1-(5-tert-butyl-3-(2,2,4-trimethyl-3-oxopiperazine-1-carbonyl)thiophen-2-yl)-3-(4-methyl-3-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)phenyl)urea | 1207877-58-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 1-(5-tert-butyl-3-(2,2,4-trimethyl-3-oxopiperazine-1-carbonyl)thiophen-2-yl)-3-(4-methyl-3-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)phenyl)urea
• 英文别名: 1-[5-Tert-butyl-3-(2,2,4-trimethyl-3-oxopiperazine-1-carbonyl)thiophen-2-yl]-3-[4-methyl-3-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]phenyl]urea
• CAS: 1207877-58-4
• 化学式: C₃₄H₄₅N₇O₃S
• 分子量: 631.842
• InChiKey: FIDCNZNPMQQAHO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.3
• 重原子数：
  45
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  129
• 氢给体数：
  2
• 氢受体数：
  7

文献信息

• UREA INHIBITORS OF MAP KINASES
  申请人：NGUYEN Duyan

  公开号：US20100041642A1

  公开（公告）日：2010-02-18

  Urea containing compounds that inhibit MAP kinases, pharmaceutical compositions including such compounds and methods for using these compounds to treat inflammatory diseases and cancer are described herein.

  本文描述了含有抑制MAP激酶的尿素类化合物、包括这些化合物的药物组合物以及使用这些化合物治疗炎症性疾病和癌症的方法。
• [EN] UREA DERIVATIVES AS INHIBITORS OF MAP KINASES<br/>[FR] DÉRIVÉS D'URÉE SERVANT D'INHIBITEURS DE MAP KINASES
  申请人：LOCUS PHARMACEUTICALS INC

  公开号：WO2010019930A1

  公开（公告）日：2010-02-18

  Urea containing compounds that inhibit MAP kinases, pharmaceutical compositions including such compounds and methods for using these compounds to treat inflammatory diseases and cancer are described herein.